Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      LA ROCHE-POSAY LAUNCHES NEW ANTI-AGING FACE SUNSCREEN CLINICALLY TESTED ON ALL SKIN TYPES


      News provided by

      La Roche-Posay

      May 02, 2022, 08:07 ET

      Share this article

      Share this article


      The new multi-benefit formula is made with key dermatological ingredients and Cellox-B3 Shield® technology that goes beyond sun protection

      NEW YORK, May 2, 2022 /PRNewswire/ -- According to the American Academy of Dermatology, skin cancer is the most common cancer in the United States with one in five Americans developing skin cancer in their lifetime. Regular daily use of an SPF 15 or higher sunscreen reduces the risk of developing melanoma by 50 percent[1]. In 2010, La Roche-Posay introduced the SOS – Save Our Skin campaign to inform the public about the dangers of UV rays and the importance of practicing sun safe behaviors in order to prevent skin cancer. The brand's mission is to encourage consumers to adopt sun safe habits, by offering a complete assortment of sunscreens that meet the needs of all ages, skin types, and tones and promoting sun safe behavior.

      Continue Reading
      La Roche-Posay
      La Roche-Posay

      Research shows people who use sunscreen with an SPF of 15 or higher daily show 24 percent less skin aging than those who do not use sunscreen daily[2]. La Roche-Posay's new Anthelios UV Correct SPF 70 Daily Anti-Aging Face Sunscreen is formulated with Cellox-B3 Shield® technology to correct and protect the skin from signs of sun damage. This sheer finish lotion blends easily on all skin tones in oxybenzone and octinoxate-free formula.

      La Roche-Posay's exclusive Cellox-B3 Shield® technology combines photostable UVA/UVB filters to deliver broad spectrum protection and powerful antioxidant protection with Senna Alata, a tropical leaf extract known to defend skin cells against damaging free radicals caused by the sun. Cellox-B3 Shield® also contains niacinamide, a form of vitamin B3, known for its ability to help visibly fade skin discoloration.

      "Recent research has shown that niacinamide can help visibly reduce signs of sun damage, like discoloration. This La Roche-Posay sunscreen incorporates dermatologist recommended ingredients like UVA/UVB protection, antioxidants, and Niacinamide in order to provide a daily anti-aging sunscreen solution," says Board Certified Dermatologist, Dr. Anna Karp.

      Anthelios UV Correct SPF 70 Anti-Aging Face Sunscreen is formulated with dermatologist recommended ingredients like niacinamide, and ingredients known to protect and correct sun-damaged skin like antioxidants and its Cellox-B3 Shield®. This lightweight sunscreen delivers a unique dual action that:

      1.       Helps visibly correct signs of sun damage on all skin tones
      2.       Helps protect the skin from the sun's harmful rays

      La-Roche-Posay has a strict formulation charter that goes beyond international cosmetic regulations. Anthelios UV Correct SPF 70 Anti-Aging Face Sunscreen has undergone rigorous consumer and clinical testing across and all skin tones. The sheer and lightweight formula demonstrated the ability to reveal more even, smoother, healthier looking skin; reduce visible signs of sun damage; blends easily on all skin tones, and protects the skin from the sun's harmful rays.

      ANTHELIOS UV CORRECT SPF 70 DAILY ANTI-AGING FACE SUNSCREEN KEY INGREDIENTS:

      • CELLOX-B3 Shield Technology: Advanced protection with UVA/UVB filters + antioxidants + niacinamide
        • UVA/UVB PROTECTION: Broad spectrum SPF 70
        • ANTIOXIDANTS: Senna Alata + Vitamin E
          • Defends against damaging free radicals
        • NIACINAMIDE: A form of vitamin B3, niacinamide is a water-soluble vitamin. It is widely used in dermatology to help visibly fade skin discoloration.

      FORMULATION CHARTER: La Roche-Posay products are developed using a strict formulation charter with a minimal number of ingredients. Every product undergoes stringent clinical testing for efficacy and safety. Anthelios UV Correct Daily Anti-Aging Face Sunscreen SPF 70:

      • Helps visibly correct signs of sun damage such as uneven skin tone, fine lines, and rough skin
      • Reveals more even, smoother, healthier looking skin
      • Helps protect the skin with CELLOX-B3 shield technology
      • Blends easily on all skin tones
      • Helps reduce visible signs of sun damage
      • Oxybenzone-free
      • Octinoxtate-free
      • Paraben-free
      • Fragrance-free
      • Non-comedogenic
      • Dermatologist tested for safety
      • Sensitive skin tested
      • Allergy tested

      Skin cancer is the only type of cancer visible to the naked eye and, if diagnosed early enough, 99%[3] can be treated effectively. Regular skin checks, whether through a dermatologist or self-checking at home, serve a critical role in the early detection of skin cancer. For the last ten years, La Roche-Posay has partnered with dermatologists to provide almost 20,000 free skin cancer screenings across the country. Year after year, the brand partners with the Women's Dermatologic Society (WDS) to provide skin cancer screenings, sun damage assessments, sun safety materials, and complimentary samples to the public. In honor of this Melanoma Monday, La Roche-Posay is part of a companywide skin check at L'Oréal headquarters and offices across the country.

      La Roche-Posay Anthelios UV Correct Daily Anti-Aging Face Sunscreen SPF 70 has a suggested retail price of $34.99 and can be purchased at select CVS, Walgreens, Target and Ulta stores and can be purchased online at www.laroche-posay.us, Amazon, LovelySkin, Dermstore, Skinstore and Skincarerx.

      About LA ROCHE-POSAY

      Recommended by 90,000 dermatologists worldwide[i], La Roche-Posay's mission is to offer life-changing dermatological skincare. Created by a French pharmacist in 1975, the brand is now available in over 60 countries. It offers a unique range of daily skincare developed for every skin type to address various skin concerns and complement prescription treatments. At the center of the brand is the exclusive selenium-rich La Roche-Posay Thermal Spring Water, a core ingredient in its skincare formulas known for its soothing and antioxidant properties that is sourced from its Thermal Center in France, the first Dermatology Center in Europe. The products are developed using a strict safety and formulation charter with a minimal number of ingredients and are formulated at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety with over 750+ studies and 25 years of extensive research, even on sensitive skin. The key La Roche-Posay product ranges are: Lipikar (dry skin), Anthelios (photoprotection), Effaclar (acne) and Toleriane (sensitive skin).

      For additional information about La Roche-Posay, visit www.laroche-posay.us and follow La Roche-Posay USA on Facebook, Instagram and Twitter @LaRochePosayUSA


      [1] Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29(3):257-263.

      [2] Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med 2013; 158(11):781-790.

      [3] Skin Cancer Foundation 


      SOURCE La Roche-Posay

      Modal title

      Also from this source

      GLOBAL STREAMERS TURN WORLD GAMING DAY INTO A GLOBAL FIGHT FOR CANCER SUPPORT WITH LA ROCHE-POSAY USA ON DISCORD

      GLOBAL STREAMERS TURN WORLD GAMING DAY INTO A GLOBAL FIGHT FOR CANCER SUPPORT WITH LA ROCHE-POSAY USA ON DISCORD

      During World Gaming Day today, La Roche-Posay will host a new edition of its Gaming For Cause livestream campaign where top gamer Tyler "Ninja"...

      La Roche-Posay Introduces Anthelios UV Defense SPF 50 Featuring BEMT, The First Sun Filter Approved by the FDA in Over 25 Years

      La Roche-Posay Introduces Anthelios UV Defense SPF 50 Featuring BEMT, The First Sun Filter Approved by the FDA in Over 25 Years

      La Roche-Posay introduces Anthelios UV Defense SPF 50 Sunscreen, featuring Bemotrizinol (BEMT), the first UV filter approved by the FDA in over 25...

      More Releases From This Source

      Explore

      Retail

      Retail

      Household, Consumer & Cosmetics

      Household, Consumer & Cosmetics

      New Products & Services

      New Products & Services

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.